Sun Pharma has agreed a takeover deal with US biotech Checkpoint Therapeutics, which recently claimed FDA approval for its first drug but is also running low on cash. The Indian pharma group – which ...
Sweida is entering a perilous new phase – one in which internal division is no longer a tragic byproduct of the Syrian ...
Discord is joining in on the end-of-year recap fun akin to Spotify Wrapped or Apple Music Replay with Discord Checkpoint, and it’s rolling out over the next few days, the popular communication ...
The year is quickly coming to an end, and that means tech platforms are tripping over themselves to roll out their year-end recaps—all hoping to capture the virality that Spotify’s Wrapped ...
Umama Ali is an experienced content writer with a passion for gaming. He has been immersed in video games for as long as he can remember. When he is not playing video games, he can be found playing ...
GameSpot may get a commission from retail offers. The feeling of reaching the peak in Peak is one of satisfaction. The feeling after slipping into poison, falling off a cliff, or overestimating your ...
When Parliament becomes a theatre and the Constitution a prop, the show isn’t democracy — it’s deception. Speaker of Parliament Jacob Mudenda is directing, Minister of Justice, Legal and Parliamentary ...
EXCLUSIVE: Joshua Zeman’s Oscar-contending documentary Checkpoint Zoo will become available to rent at home this Saturday to mark World Animal Day, Abramorama and GATHR announced today. Under the ...
Federal agents on Wednesday set up a checkpoint in a Washington, D.C., neighborhood sparking a backlash from protesters in an escalation of President Donald Trump's crackdown on crime in the capital.
Hosted on MSN
Vibe Checkpoint — Unity, Voices, and Real Talk
What on Earth just happened to the stock market? Why Trump’s ‘quiet, piggy’ comment should be seen as a warning Why Biden DOJ didn't release Jeffrey Epstein files Zara Larsson fan becomes star after ...
Sun Pharmaceutical Industries has agreed to acquire Checkpoint Therapeutics, Inc. for $4.10 per share, a 65% premium to last traded price, post-FDA approval of Unloxcyt for metastatic cutaneous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback